Prucalopride: A recently approved drug by the food and drug administration for chronic idiopathic constipation
Open Access
- 1 January 2019
- journal article
- editorial
- Published by Medknow in International Journal of Applied and Basic Medical Research
- Vol. 9 (1), 1-2
- https://doi.org/10.4103/ijabmr.ijabmr_412_18
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Prucalopride succinate for the treatment of constipation: an updateExpert Review of Gastroenterology & Hepatology, 2015
- Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2008
- Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxativesGut, 2008
- A Placebo-Controlled Trial of Prucalopride for Severe Chronic ConstipationThe New England Journal of Medicine, 2008